PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10366426-5	1999	The results show that cis-diamminedichloroplatinum (CDDP) resistance was overcome by treatment with nontoxic doses of CDDP in combination with anti-IL-6 mAb.	Cisplatin	22-50	interleukin 6	Homo sapiens	148-152	
10366426-5	1999	The results show that cis-diamminedichloroplatinum (CDDP) resistance was overcome by treatment with nontoxic doses of CDDP in combination with anti-IL-6 mAb.	Cisplatin	52-56	interleukin 6	Homo sapiens	148-152	
10366426-8	1999	The current studies show that anti-IL-6 mAb sensitized CDDP-resistant K562 cells to CDDP by induction of apoptotic death and the reduction of glutathione levels might be implicated in the enhanced cytotoxicity observed.	Cisplatin	55-59	interleukin 6	Homo sapiens	35-39	
10366426-8	1999	The current studies show that anti-IL-6 mAb sensitized CDDP-resistant K562 cells to CDDP by induction of apoptotic death and the reduction of glutathione levels might be implicated in the enhanced cytotoxicity observed.	Cisplatin	84-88	interleukin 6	Homo sapiens	35-39